[Federal Register Volume 83, Number 216 (Wednesday, November 7, 2018)]
[Notices]
[Page 55739]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24287]



[[Page 55739]]

-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation Nos. 701-TA-590 and 731-TA-1397 (Final)]


Sodium Gluconate, Gluconic Acid, and Derivative Products From 
China

Determinations

    On the basis of the record \1\ developed in the subject 
investigations, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that an industry in the United States is materially injured by 
reason of imports of Sodium Gluconate, Gluconic Acid, and Derivative 
Products from China, provided for in subheadings 2918.16.10, 
2918.16.50, and 2932.20.50 of the Harmonized Tariff Schedule of the 
United States, that have been found by the U.S. Department of Commerce 
(``Commerce'') to be sold in the United States at less than fair value 
(``LTFV''), and to be subsidized by the government of China.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission, pursuant to sections 705(b) and 735(b) of the Act 
(19 U.S.C. 1671d(b) and 19 U.S.C. 1673d(b)), instituted these 
investigations effective November 30, 2017, following receipt of a 
petition filed with the Commission and Commerce by PMP Fermentation 
Products (``PMP''), Inc., Peoria, Illinois. The final phase of the 
investigations was scheduled by the Commission following notification 
of preliminary determinations by Commerce that imports of Sodium 
Gluconate, Gluconic Acid, and Derivative Products from China were 
subsidized within the meaning of section 703(b) of the Act (19 U.S.C. 
1671b(b)) and sold at LTFV within the meaning of 733(b) of the Act (19 
U.S.C. 1673b(b)). Notice of the scheduling of the final phase of the 
Commission's investigations and of a public hearing to be held in 
connection therewith was given by posting copies of the notice in the 
Office of the Secretary, U.S. International Trade Commission, 
Washington, DC, and by publishing the notice in the Federal Register on 
July 18, 2018 (83 FR 33944). The hearing was held in Washington, DC, on 
September 18, 2018, and all persons who requested the opportunity were 
permitted to appear in person or by counsel.
    The Commission made these determinations pursuant to sections 
705(b) and 735(b) of the Act (19 U.S.C. 1671d(b) and 19 U.S.C. 
1673d(b)). It completed and filed its determinations in these 
investigations on October 31, 2018. The views of the Commission are 
contained in USITC Publication 4834 (October 2018), entitled Sodium 
Gluconate, Gluconic Acid, and Derivative Products from China: 
Investigation Nos. 701-TA-590 and 731-TA-1397 (Final).

    By order of the Commission.

    Issued: November 1, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018-24287 Filed 11-6-18; 8:45 am]
 BILLING CODE 7020-02-P